*ST Pharma announced on April 30, 2024 that the number of shareholders of the company as of April 19, 2024 was 33,400, a decrease of 2,316 or 6.49% from the previous period (March 31, 2024).
*The number of shareholders of ST Pharma is lower than the industry average. According to Choice data, as of April 19, 2024, the average number of shareholders of listed companies in the pharmaceutical and biotechnology industry is 33,900. Among them, the number of shareholders of the company is in the range of 5,000~15,000, accounting for the highest proportion, 28.84%.
Distribution of the number of shareholders in the pharmaceutical and biological industry
Number of shareholders and share price
Since September 30, 2023, the number of shareholders of the company has increased significantly, with an increase of 31.23%. From September 30, 2023 to April 19, 2024, the stock price decreased by 23.42%.
Number of shareholders and share price
Number of shareholders and share capital
As of April 19, 2024, the company's latest total share capital is 220 million shares, all of which are outstanding shares. The average number of outstanding shares held by households increased from 6,156 shares in the previous period to 6,583 shares, and the average market value of households was 56,600 yuan.
The average amount of shares held by each household
*The market value of ST large pharmacists is lower than the industry average. According to Choice data, as of April 19, 2024, the average market value of A-share listed companies in the pharmaceutical and biological industry is 400,300 yuan. Among them, 25.31% of the company's households hold a circulating stock market value in the range of 130,000~250,000.
Distribution of per capita circulating market value of the pharmaceutical and biological industry
Disclaimer: This article is based on big data and is for reference only and does not constitute any investment advice.